Navigation Links
Gene's novel role may provide key to treating liver and neurodegenerative diseases
Date:7/2/2009

Scientists at Singapore's Bioprocessing Technology Institute (BTI) have made a novel discovery about how the gene, "Fas-apoptosis inhibitory molecule" (FAIM), protects both immune and liver cells from apoptosis, or programmed cell death.

Their research is published in the current journal Cell Death and Differentiation.

The scientists, Jianxin Huo, Ph.D., and Shengli Xu, Ph.D., also discovered that this process may possibly be manipulated for clinical application and proposed the first-to-be-published in-animal model to study the role of FAIM in detail.

FAIM triggers a mechanism that ultimately impedes an important pathway to apoptosis, which is mediated by a key protein called Fas. Using their mouse model, the scientists elucidated part of the sequence of molecular events that regulates Fas-mediated apoptosis.

They found that FAIM functioned as a key switch in the Fas cell death circuit, which could be turned up or down to prolong or decrease cell survival.

Therefore, in principle, this gene could make a good target for drug intervention in either liver cirrhosis in which the target is to prolong cell survival, or in cancer in which the goal is to induce tumour cell death.

BTI Scientific Director Lam Kong Peng, Ph.D., who heads the immunology group that conducted the research, said, "We had earlier identified FAIM to be valuable in increasing the yield of biologics, and that had been one of the main focuses of BTI's research until now. We were extremely pleased to be able to establish that FAIM's function is preserved across both liver and immune cells, as this underscores its critical role in regulating cell death in disease."

The immunology team at BTI, one of the research institutes sponsored by Singapore's A*STAR (Agency for Science, Technology and Research), aims to further characterize the role of FAIM in liver cancer and other debilitating diseases.

According to Drs. Huo a
'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pathway links inflammation, angiogenesis and breast cancer
2. Traffic Fumes Plus Genes Boosts Kids Asthma Risk
3. New Database to Help Speed Search for Bipolar Disorder Genes
4. Is Perfect Pitch All in the Genes?
5. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
6. Genes Boost Risk for Rheumatoid Arthritis, Lupus
7. The genes involved in rheumatoid arthritis identified
8. If you think cancer genes are simple, you dont know JAK
9. Test for lung cancer looks for discomforting quiet among protective genes
10. Hushed Genes Might Mean Higher Lung Cancer Risk
11. EURYI project to understand how the brain wires during embryogenesis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , SOUTHFIELD, Mich., Dec. 1 /PRNewswire-First...SE: FMR ) ("First Mercury" or the "Company") ann...f Directors declared a quarterly cash dividend of ...shareholders of record at the close of business on...inancial Corporation ,, First Mercury Financia...
(Date:12/1/2009)... identify those who would benefit from liver surge...Y, Dec. 1 (HealthDay News) -- A CT scan of liver t...y help predict overall survival after chemotherapy...stin) to cytotoxic chemotherapy has been shown to ...ectal cancer and to produce better results in pati...
(Date:12/1/2009)...LADELPHIA (December 1, 2009) Wistar Institute re... Pennsylvania and New York University have identif...ate early-stage lung tumors in people at high risk...ed online December 1 in Cancer Research , a journ..., could lead to a simple blood test to detect lung...
(Date:12/1/2009)... Ever thought you could quit s...vin Arthur Smith,s groundbreaking new system for q...ermanent. In just twenty eight days your cravings ... (PRWEB) December 1, 2009 -...g her eight-year addiction to nicotine, smoking at...
(Date:12/1/2009)... , LEHIGH VALLEY, Pa., Dec. 1 /PRNewswire-Firs...t has completed the previously announced sale of t...s, marketed under the Airthane® and Versathan... subsidiary of global polyurethane chemicals produ...Products, manufacturing facility in Paulsboro, N.J...
Breaking Medicine News(10 mins):Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2
...,Corporation (Nasdaq: SMTS ) announced today that... to repurchase up to $15 million of its common,sha...e open market or in,privately negotiated transacti...186 common shares outstanding as of April,2, 2008....
... for lung invasion, study shows , , THURSD...nd to spread to specific tissues, and now research...pens. , Working with breast tumors, Joan Massague,...ling "relay" that enables the cancer to molecularl...
...b &,Ellis Company (NYSE: GBE ), a leading real es...report released today that aging baby boomers and,...fuel demand for,healthcare properties over the nex...llis, Chief Economist and author of the,report., ...
...roviders, and Patients, WASHINGTON, April 3, 2008...rganizations (AAPPO), in collaboration,with DMAA: ... a diabetes,toolkit for PPO executives to help hea...: http://www.newscom.com/cgi-bin/prnh/20060126/CL...
...n A. Clements is the recipient of the 2008 Pollin ...to our understanding of how lungs hold air, and to...piratory distress syndrome (RDS) in infants. Once ...t international award for pediatric research, reco...
...a Hall Institute, Professor Suzanne Cory, is one o...omson Scientific Citation Awards announced at the ...tific, a US-based international information analys...per their published research has had over a period...
Other Medicine News:Health News:Somanetics Announces Share Repurchase Program 2Health News:Molecular Cause of Breast Cancer Metastasis Discovered 2Health News:Molecular Cause of Breast Cancer Metastasis Discovered 3Health News:Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals 2Health News:Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals 3Health News:Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals 4Health News:Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals 5Health News:AAPPO Releases Diabetes Toolkit to Spur Action on Better Diabetes Care 2Health News:AAPPO Releases Diabetes Toolkit to Spur Action on Better Diabetes Care 3Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 2Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 3Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 4Health News:Professor Suzanne Cory honored with national citation award 2
(Date:12/1/2009)...BUQUERQUE, N.M., Dec. 1 Exagen Dia... that discovers, develops and markets proprietary ...Scott Glenn as chairman of the company,s board of ... to joining Exagen, Glenn was managing partner of ... of successful biomedical companies including Prom...
(Date:12/1/2009)..., BEIJING, Dec. 1 /PRNewswire-Asia/ -- Sino...r of biopharmaceutical products in China, announce...rder for its H1N1 vaccine, PANFLU.1(TM),from Chin...y for the national,purchase plan. Under this purch...ional one million doses of PANFLU.1 (TM) (15ug/0.5...
(Date:12/1/2009)..., REDWOOD CITY, Calif., Dec. 1 Cod...ationship and the signing of its second agreement ..., the world,s largest generic drug manufacturer. ...eutical products. Codexis announced an earlier ag...w agreement, Teva will use Codexis biocatalysis te...
Breaking Medicine Technology:Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Codexis Expands Collaboration with Teva 2Newly found DNA catalysts cleave DNA with water molecule 9589 1Newly found DNA catalysts cleave DNA with water molecule 9589 2Researchers develop new more sensitive assay for detecting DNA methylation in colon cancer 9586 1Researchers develop new more sensitive assay for detecting DNA methylation in colon cancer 9586 2Researchers develop new more sensitive assay for detecting DNA methylation in colon cancer 9586 3Web Is Becoming One Stop Shopping for Health Help 54591 1Web Is Becoming One Stop Shopping for Health Help 54591 2Web Is Becoming One Stop Shopping for Health Help 54591 3
...s of Arimidex (anastrozole) over tamoxifen at prev...crease over time - even four years after ...ec. 14 New data from ATAC*, one of the,world,s la...l women with,early breast cancer, reinforce that a...ee, for longer. For the first time, anastrozole ha...
...ON, Mass., Dec. 18 Alseres,Pharmaceuticals, Inc.,...olled,the first subject in the initial stage of th... (POET-2) Phase III clinical trial program. This,s...Birmingham trial site,under the direction of Princ...nd Chairman of the Department of Neurology., ALTR...
Other Medicine Technology:Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 2Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 3Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 4Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 5Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 2Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 3Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 4Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 5
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: